⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1179397 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4224664 | 0.98 | ALDH1A1 (0.95) | — | |
| Hydrochloric Acid SCHEMBL1178615 | 0.98 | ALDH1A1 (0.95) | — | |
| SCHEMBL11205997 | 0.83 | ALDH1A1 (0.70) | — | |
| SCHEMBL31308700 | 0.82 | ALDH1A1 (0.69) | — | |
| Hydrochloric Acid SCHEMBL29185155 | 0.81 | ALDH1A1 (0.68) | — | |
| SCHEMBL765054 | 0.79 | — | — | |
| SCHEMBL9367446 | 0.79 | — | — | |
| SCHEMBL4212829 | 0.79 | — | — | |
| SCHEMBL31648802 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676481-A1 | COMBINATION OF BETA-2-ADRENERGIC RECEPTOR AGONISTS AND GLP-1 RECEPTOR AGONISTS FOR USE IN TREATING HYPERGLYCAEMIA | Atrogi AB (SE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4665321-A1 | COMBINATIONS OF BETA 2-ADRENERGIC RECEPTOR AGONISTS AND METFORMIN FOR USE IN TREATING OBESITY AND REDUCING BODY FAT | Atrogi AB (SE) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024184408-A1 | COMBINATION OF BETA-2-ADRENERGIC RECEPTOR AGONISTS AND GLP-1 RECEPTOR AGONISTS FOR USE IN TREATING HYPERGLYCAEMIA | ATROGI AB (SE) | 2024-09-12 | — | — | WO | disclosed |
| US-20240277681-A1 | A SYNERGISTIC COMPOSITION FOR INHIBITING VASCULAR CALCIFICATION | Celagenex Research (India) Pvt. Ltd. (IN) | 2024-08-22 | — | — | US | disclosed |
| WO-2024170727-A1 | COMBINATIONS OF BETA 2-ADRENERGIC RECEPTOR AGONISTS AND METFORMIN FOR USE IN TREATING OBESITY AND REDUCING BODY FAT | ATROGI AB (SE) | 2024-08-22 | — | — | WO | disclosed |
| CN-116898848-A | High penetration prodrug compositions and pharmaceutical compositions for treating pulmonary diseases | 苏州泰飞尔医药有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-107929743-B | High penetration prodrug compositions and pharmaceutical compositions for treating pulmonary diseases | 苏州泰飞尔医药有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-111491936-B | Macrocyclic compounds as PDE1 inhibitors | H.隆德贝克有限公司 | 2023-07-04 | — | — | CN | disclosed |